» Articles » PMID: 35250566

The Mitochondrial Deubiquitinase USP30 Regulates AKT/mTOR Signaling

Overview
Journal Front Pharmacol
Date 2022 Mar 7
PMID 35250566
Authors
Affiliations
Soon will be listed here.
Abstract

Mitophagy is an intracellular mechanism to maintain mitochondrial health by removing dysfunctional mitochondria. The E3 ligase Parkin ubiquitinates the membrane proteins on targeted mitochondria to initiate mitophagy, whereas USP30 antagonizes Parkin-dependent mitophagy by removing ubiquitin from Parkin substrates. The AKT/mTOR signaling is a master regulator of cell proliferation, differentiation, apoptosis, and autophagy. Although mounting evidence suggests that perturbations in the AKT/mTOR signaling pathway may contribute to mitophagy regulation, the specific mechanisms between Parkin/USP30 and AKT/mTOR signaling have not been elucidated. In this study, we employ a set of genetic reagents to investigate the role of Parkin and USP30 in regulating the AKT/mTOR signaling during mitophagy. We demonstrated that, in the setting of mitochondrial stress, the AKT/mTOR signaling is regulated, at least in part, by the activity of Parkin and USP30. Parkin inhibits AKT/mTOR signaling following an mitochondrial stress, thereby promoting apoptosis. However, USP30 overexpression antagonizes the activity of Parkin to sustain AKT/mTOR activity and inhibit apoptosis. These findings provide new insights into Parkin and USP30's role in apoptosis and suggest that inhibiting USP30 might provide a specific strategy to synergize with AKT/mTOR inhibitors in cancer treatment.

Citing Articles

Astaxanthin Inhibits HO-Induced Excessive Mitophagy and Apoptosis in SH-SY5Y Cells by Regulation of Akt/mTOR Activation.

Yan T, Ding F, Zhang Y, Wang Y, Wang Y, Zhang Y Mar Drugs. 2024; 22(2).

PMID: 38393028 PMC: 10890442. DOI: 10.3390/md22020057.


Inhibition of USP30 Promotes Mitophagy by Regulating Ubiquitination of MFN2 by Parkin to Attenuate Early Brain Injury After SAH.

Liu Y, Yao C, Sheng B, Zhi S, Chen X, Ding P Transl Stroke Res. 2023; .

PMID: 38147294 DOI: 10.1007/s12975-023-01228-3.


The roles of ubiquitination in AML.

Wei Z, Su L, Gao S Ann Hematol. 2023; 103(9):3413-3428.

PMID: 37603061 DOI: 10.1007/s00277-023-05415-y.


A review of deubiquitinases and thier roles in tumorigenesis and development.

Liang X, Wang S, Liu B, Chen J, Cao Z, Chu F Front Bioeng Biotechnol. 2023; 11:1204472.

PMID: 37251574 PMC: 10213685. DOI: 10.3389/fbioe.2023.1204472.


Targeting Deubiquitinating Enzymes (DUBs) That Regulate Mitophagy via Direct or Indirect Interaction with Parkin.

Tsefou E, Ketteler R Int J Mol Sci. 2022; 23(20).

PMID: 36292958 PMC: 9603086. DOI: 10.3390/ijms232012105.

References
1.
DAmours D, Sallmann F, Dixit V, Poirier G . Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J Cell Sci. 2001; 114(Pt 20):3771-8. DOI: 10.1242/jcs.114.20.3771. View

2.
Estruch M, Reckzeh K, Vittori C, Centio A, Ali M, Engelhard S . Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy. Leukemia. 2020; 35(7):2030-2042. DOI: 10.1038/s41375-020-01094-0. View

3.
Vara-Perez M, Felipe-Abrio B, Agostinis P . Mitophagy in Cancer: A Tale of Adaptation. Cells. 2019; 8(5). PMC: 6562743. DOI: 10.3390/cells8050493. View

4.
Sowa M, Bennett E, Gygi S, Harper J . Defining the human deubiquitinating enzyme interaction landscape. Cell. 2009; 138(2):389-403. PMC: 2716422. DOI: 10.1016/j.cell.2009.04.042. View

5.
Gobeil S, Boucher C, Nadeau D, Poirier G . Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ. 2001; 8(6):588-94. DOI: 10.1038/sj.cdd.4400851. View